These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

654 related items for PubMed ID: 11219554

  • 1. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
    Meurer LN, Slawson JG.
    J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
    [No Abstract] [Full Text] [Related]

  • 2. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS, Kaye JA, Russmann S, Jick H.
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [Abstract] [Full Text] [Related]

  • 3. The truth about oral contraceptives and venous thromboembolism.
    Shulman LP, Goldzieher JW.
    J Reprod Med; 2003 Nov; 48(11 Suppl):930-8. PubMed ID: 14686030
    [Abstract] [Full Text] [Related]

  • 4. [Changed routines in connection with first prescription of oral contraceptives. Lower risk of venous thromboembolism with levonorgestrel preparations].
    Milsom I, Odlind V, von Schoultz B, Ostlund I, Persson E.
    Lakartidningen; 2002 Jan 10; 99(1-2):10-2, 15. PubMed ID: 11871161
    [No Abstract] [Full Text] [Related]

  • 5. Oral contraceptives and venous thromboembolism: an epidemiological review.
    Lidegaard O.
    Eur J Contracept Reprod Health Care; 1996 Jan 10; 1(1):13-20. PubMed ID: 9678133
    [Abstract] [Full Text] [Related]

  • 6. Effects on hemostatic variables of desogestrel- and gestodene-containing oral contraceptives in comparison with levonorgestrel-containing oral contraceptives: a review.
    Winkler UH.
    Am J Obstet Gynecol; 1998 Sep 10; 179(3 Pt 2):S51-61. PubMed ID: 9753311
    [Abstract] [Full Text] [Related]

  • 7. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD, Lawrenson RA, Thompson CR, Kennedy JG, Hambleton IR.
    Lancet; 1997 Jan 11; 349(9045):83-8. PubMed ID: 8996419
    [Abstract] [Full Text] [Related]

  • 8. [What does the micropill bring?].
    Mall-Haefeli M.
    Ther Umsch; 1986 May 11; 43(5):365-71. PubMed ID: 2941889
    [No Abstract] [Full Text] [Related]

  • 9. Third generation oral contraceptives containing desogestrel and gestodene and the risk of thrombosis.
    Griffin JP.
    Adverse Drug React Toxicol Rev; 1996 Mar 11; 15(1):5-7. PubMed ID: 8920631
    [No Abstract] [Full Text] [Related]

  • 10. [Third-generation oral contraceptives--how big is the risk of venous thrombosis?].
    Iversen OE.
    Tidsskr Nor Laegeforen; 2004 Jun 03; 124(11):1521-2. PubMed ID: 15195157
    [No Abstract] [Full Text] [Related]

  • 11. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
    Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C.
    Lancet; 1995 Dec 16; 346(8990):1589-93. PubMed ID: 7500750
    [Abstract] [Full Text] [Related]

  • 12. The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.
    Lewis MA, Heinemann LA, MacRae KD, Bruppacher R, Spitzer WO.
    Contraception; 1996 Jul 16; 54(1):5-13. PubMed ID: 8804801
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Third generation oral contraceptives and risk of venous thrombosis].
    Olsen J.
    Ugeskr Laeger; 2002 Jan 14; 164(3):346. PubMed ID: 11816336
    [No Abstract] [Full Text] [Related]

  • 17. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
    Middeldorp S, Meijers JC, van den Ende AE, van Enk A, Bouma BN, Tans G, Rosing J, Prins MH, Büller HR.
    Thromb Haemost; 2000 Jul 14; 84(1):4-8. PubMed ID: 10928461
    [Abstract] [Full Text] [Related]

  • 18. Do third-generation oral contraceptives (OCs) increase the risk of venous thrombosis?
    Sapp AV, Lindbloom EJ.
    J Fam Pract; 2001 Oct 14; 50(10):893. PubMed ID: 11674894
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.